Trastuzumab emtansine CAS 1018448-65-1

Purity 97%+In StockPharmaceutical Standards
CAS No.1018448-65-1
Molecular Formula-
Molecular Weight973.55 g/mol
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

Trastuzumab emtansine CAS 1018448-65-1 chemical structure

Description

Compared with other compounds in its class, the molecular weight of 973.55 g/mol gives Trastuzumab emtansine distinctive chromatographic separation conditions and mass-spectrometry parameter settings.

CATO supplies Trastuzumab emtansine (CAS 1018448-65-1), a certified reference material (molecular formula N/A, MW 973.55 g/mol) for analytical method development and quality control.

Trastuzumab emtansine is supplied as a fully characterized reference material; its structural identity, assigned purity, and stability data are documented in the batch-specific Certificate of Analysis (COA).

This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.

CATO manufactures Trastuzumab emtansine under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Molecular FormulaC47H63AClN5O13S
Molecular Weight973.55 g/mol
Purity97%+
StorageStore in a cool place (≤25°C), protect from light, keep sealed and dry
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions
Degree of Unsaturation (DBE)18.5
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1988
Halogen ContentCl-containing
Nitrogen Atoms5
Sulfur Atoms1

Related Trastuzumab Standards

Recommended Standards

Why CATO?